Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

BMC Infectious Diseases, December 1, 2016

Mucormycosis is a rare but devastating fungal infection primarily affecting immunocompromised patients such as those with hematological malignancy, bone marrow and solid organ transplantation, and patients with diabetes, and, even more rarely, immunocompetent patients. The objective of this study was to assess the prevalence and burden, both clinical and economic, of mucormycosis among hospitalized patients in the U.S.

View article


Kontoyiannis DP, Yang HSong J, Kelkar SS, Yang X, Azie N, Harrington R, Fan A, Lee E, Spalding JR